Differences in self-monitored, blood glucose test strip utilization by therapy for type 2 diabetes mellitus
Crossref DOI link: https://doi.org/10.1007/s00592-015-0823-z
Published Online: 2016-03-14
Published Print: 2016-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tavares, Ruben
Duclos, Marc
Brabant, Marie-Josée
Checchin, Daniella
Bosnic, Nevzeta
Turvey, Katherine
Terres, Jorge Alfonso Ross
Funding for this research was provided by:
GlaxoSmithKline (GB) (HO-13-14410)
License valid from 2016-03-14